Urinalysis Market: Growth, Size, Share, and Trends

Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029

Report Code: MD 3259 Jun, 2024, by marketsandmarkets.com

Market Growth Outlook Summary

The global urinalysis market growth forecasted to transform from $4.3 billion in 2024 to $6.8 billion by 2029, driven by a CAGR of 9.6%. This market has grown significantly over the last few years due to the increasing adoption of PoC testing products in home care and hospitals. The convenience of these tools has driven their adoption, particularly considering the rising prevalence of chronic and lifestyle diseases, technological advancements in PoC testing products, growing patient awareness of PoC testing, shortage of technicians to conduct conventional lab tests, and the rising number of Clinical Laboratory Improvement Amendments (CLIA) approvals for PoC tests. Point-of-care testing (POCT) in urine analysis positively impacts the operational efficiency and care of patients with CKD.

Urinalysis Market Trends

Urinalysis  Market

To know about the assumptions considered for the study, Request for Free Sample Report

Urinalysis  Market

Urinalysis Market Dynamics

DRIVER: Rising geriatric population and subsequent increase in age-associated diseases

The demand for urinalysis is propelled by the imperative to manage CKD effectively in the aging population, emphasizing its pivotal role in enhancing healthcare outcomes and addressing the unique needs of elderly patients. Advancements in urinalysis technology, such as automated analyzers and point-of-care testing (POCT), have made the process quicker, more accurate, and more convenient. These innovations are particularly beneficial in managing the health of elderly patients who require frequent testing.

RESTRAINT: High capital investments and lack of skilled laboratory technicians

An increase in the aging population is expected to cause a greater need to diagnose medical conditions, such as cancer or type 2 diabetes, through laboratory procedures.] At present, there is a significant shortage of laboratory technicians in both developed and developing nations. This is mainly attributed to the increasing patient population base, the retirement of elderly technicians, and the increasing number of cash-strapped colleges closing their clinical lab programs. Stringent requirements for licensure in many countries to practice as a clinical laboratory technologist discourage people from this profession. Thus, a gap between the supply and demand of pathologists and lab technicians worldwide restrains the market growth.

OPPORTUNITY: Technological advancements in urine analyzers

Urinalysis has undergone significant technological advancements in the past few decades. Visual analysis of test strips for early screening was initially replaced by manual strip readers, providing a better analysis of test results. With the increasing workload, automated analyzers were developed for biochemical analysis. Such systems minimize operator interference in performing tests.

Sediment analysis is conducted via manual microscopy worldwide, particularly in developing economies. However, with a higher patient count, it is difficult to perform manual sediment analysis for all patient samples. Thus, automated sediment analyzers that utilize digital microscopy or flow cytometry to identify the different infectious agents and other casts and crystals in urine samples entered the market. These devices also help standardize sediment analysis. Urinary flow cytometry is an alternative to automated microscopy, and a more thorough analysis of flow cytometric data has enabled rapid differentiation of urinary microorganisms. By introducing laboratory-on-a-chip approaches and microfluidics, new affordable applications for quantitative urinalysis and readout on cell phones may become available in the coming years.

CHALLENGE: Changing regulatory landscape

Regulatory and legal requirements for in vitro diagnostics (IVD) (including urinalysis) in the US and European countries are becoming more stringent. In the US, IVD products are defined under 21 CFR 809 and regulated under guidelines similar to medical devices. The FDA released new FDA guidance documents. Under US federal regulations, device manufacturers must submit a 510(k) application for further modifications to a device. New applications may be required for software updates, new software installation in an existing device, or any other changes made to these devices.

Urinalysis Ecosystem/Market Map

Urinalysis  Market Ecosystem

The largest share in the urinalysis industry in 2023 was held by the consumables segment, by product.

Categorized by various product, the urinalysis market includes consumables and instruments. As of 2023, the largest portion of the market was dominated by the consumables segment. Consumables, such as reagent strips, sample collection cups, and quality control solutions, are integral to urinalysis, providing the necessary materials for accurate and reliable test results. Their recurring nature ensures continuous demand, as each test requires fresh supplies. The increasing frequency of urinalysis, driven by the growing geriatric population and the prevalence of chronic diseases, further fuels the need for consumables.

Disease screening segment dominated the urinalysis industry in 2023, based on application.

On the basis of application, the urinalysis market is segmented into disease screening and pregnancy & fertility testing. The disease screening segment accounted for the largest share of the urinalysis market in 2023. Urinalysis plays a crucial role in the early detection and monitoring of various conditions such as diabetes, kidney disease, urinary tract infections, and liver disease. With an increasing global focus on preventive healthcare and early intervention, healthcare providers are prioritizing routine screenings to identify diseases at an earlier, more treatable stage. This trend is particularly significant given the aging population, which is more susceptible to chronic conditions requiring regular monitoring. The widespread adoption of urinalysis in disease screening programs, along with advancements in testing technologies that enhance accuracy and ease of use, underscores its dominance in the market.

North America accounted for the largest share of the urinalysis industry in 2023.

Categorized into six primary regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries, the urinalysis market witnessed North America taking the forefront in 2023. North America, particularly the US and Canada, boasts advanced healthcare systems with well-established infrastructure for early disease diagnosis. This infrastructure supports the adoption of innovative technologies like advanced urine analyzers.

Urinalysis  Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The major players in this market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), and Danaher (US). These players lead the market because of their extensive product portfolios and wide geographic presence.

Scope of the Urinalysis Industry

Report Metric

Details

Market Revenue in 2024

$4.3 billion

Projected Revenue by 2029

$6.8 billion

Revenue Rate

Poised to Grow at a CAGR of 9.6%

Market Driver

Rising geriatric population and subsequent increase in age-associated diseases

Market Opportunity

Technological advancements in urine analyzers

This report categorizes the urinalysis market to forecast revenue and analyze trends in each of the following submarkets:

By Product
  • Consumables
    • Pregnancy & Fertility Kits
    • Dipsticks
    • Disposables
    • Reagents
  • Instruments
    • Automated Urine Analyzers
      • Integrated Urine Analyzers
      • Sediment Urine Analyzers
        • Microscopy Analyzers
        • Flow Cytometry Analyzers
      • Biochemical Urine Analyzers
    • Semi-automated Urine Analyzers
    • Point-of-care Urine Analyzers
By Test Type
  • Pregnancy & Fertility Tests
  • Biochemical Tests
    • Laboratory Tests
    • PoC Tests
  • Sediment Urinalysis
By Application
  • Disease Screening
    • Urinary Tract Infections
    • Kidney Diseases
    • Diabetes
    • Liver Diseases
    • Other Disease Screening Applications
  • Pregnancy & Fertility Testing
By End User
  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Home Care Settings
  • Research Laboratories & Institutes
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
  • GCC Countries

Recent Developments of Urinalysis Industry:

  • In July 2023, Siemens Healthineers (Germany) opened an Innovation Center in Erlangen, Germany, which focuses on the open innovation concept for collaborations with clinical and academic partners, as well as other companies and startups.
  • In April 2023, Cardinal Health (US) announced the opening of two new distribution centers in Central Ohio, which will support its Medical segment, focusing on its US Medical Products and Distribution (USMPD) and At-home Solutions businesses.
  • In February 2023, Siemens Healthineers and Unilabs announced a multi-year agreement. Under this agreement, Unilabs will modernize its healthcare infrastructure across its network to improve customer service and quality, thereby improving patient health. Siemens Healthineers’ solutions will enhance Unilabs’ laboratory operations, throughput, and clinical equivalence across its testing network.
  • In September 2022, Sysmex Corporation launched the UF-1500 Fully Automated Urine Particle Analyzer (UF-1500) for use in urine sediment testing.
  • In May 2022, Quidel Corporation (US), a provider of rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems, announced the acquisition of Ortho Clinical Diagnostics (US).

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TABLE OF CONTENTS
 
1 INTRODUCTION 
2 RESEARCH METHODOLOGY 
3 EXECUTIVE SUMMARY 
 
4 PREMIUM INSIGHTS (Page No. - 57)
    4.1 URINALYSIS MARKET OVERVIEW 
    4.2 URINALYSIS MARKET SHARE, BY PRODUCT, 2024 VS. 2029 
    4.3 URINALYSIS MARKET SHARE, BY TEST TYPE, 2024 VS. 2029 
    4.4 URINALYSIS MARKET SHARE, BY APPLICATION, 2024 VS. 2029 
    4.5 URINALYSIS MARKET SHARE, BY END USER, 2024 VS. 2029 
    4.6 URINALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
 
5 MARKET OVERVIEW (Page No. - 61)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer
                    5.2.1.2 Rising geriatric population and subsequent increase in age-associated diseases
                    5.2.1.3 Increasing adoption of PoC urine diagnostic tests
           5.2.2 RESTRAINTS
                    5.2.2.1 Availability of refurbished urine analyzers
                    5.2.2.2 High capital investments and lack of skilled laboratory technicians
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth opportunities in emerging countries
                    5.2.3.2 Technological advancements in urine analyzers
                    5.2.3.3 Increasing government initiatives and funding for preventive care
           5.2.4 CHALLENGES
                    5.2.4.1 Changing regulatory landscape
    5.3 PRICING ANALYSIS 
    5.4 PATENT ANALYSIS 
           5.4.1 LIST OF MAJOR PATENTS
    5.5 VALUE CHAIN ANALYSIS 
    5.6 SUPPLY CHAIN ANALYSIS 
    5.7 TRADE ANALYSIS 
           5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
    5.8 ECOSYSTEM ANALYSIS 
           5.8.1 URINALYSIS MARKET: ROLE IN ECOSYSTEM
    5.9 PORTER’S FIVE FORCES ANALYSIS 
           5.9.1 THREAT OF NEW ENTRANTS
           5.9.2 THREAT OF SUBSTITUTES
           5.9.3 BARGAINING POWER OF BUYERS
           5.9.4 BARGAINING POWER OF SUPPLIERS
           5.9.5 INTENSITY OF COMPETITIVE RIVALRY
    5.10 REGULATORY LANDSCAPE 
           5.10.1 NORTH AMERICA
                    5.10.1.1 US
                    5.10.1.2 Canada
           5.10.2 EUROPE
           5.10.3 ASIA PACIFIC
                    5.10.3.1 China
                    5.10.3.2 Japan
                    5.10.3.3 India
           5.10.4 LATIN AMERICA
                    5.10.4.1 Brazil
                    5.10.4.2 Mexico
           5.10.5 MIDDLE EAST
                    5.10.5.1 Africa
           5.10.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.11 TECHNOLOGY ANALYSIS 
           5.11.1 KEY TECHNOLOGY
                    5.11.1.1 Automated urine analyzers
           5.11.2 COMPLEMENTARY TECHNOLOGY
                    5.11.2.1 Point-of-care urine analyzers
           5.11.3 ADJACENT TECHNOLOGY
                    5.11.3.1 Multiplex PCR
    5.12 KEY CONFERENCES & EVENTS IN 2024–2025 
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR URINALYSIS MARKET
    5.14 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.14.2 BUYING CRITERIA
    5.15 INVESTMENT & FUNDING SCENARIO 
    5.16 CASE STUDY ANALYSIS 
    5.17 IMPACT OF ARTIFICIAL INTELLIGENCE ON URINALYSIS MARKET 
 
6 URINALYSIS MARKET, BY PRODUCT (Page No. - 94)
    6.1 INTRODUCTION 
           6.1.1 PRIMARY NOTES
                    6.1.1.1 Key industry insights
    6.2 CONSUMABLES 
           6.2.1 PREGNANCY & FERTILITY KITS
                    6.2.1.1 Rapid accessibility and testing convenience to drive market
           6.2.2 DIPSTICKS
                    6.2.2.1 Low cost to increase adoption
           6.2.3 REAGENTS
                    6.2.3.1 Increasing use of controls and calibrators to drive market
           6.2.4 DISPOSABLES
                    6.2.4.1 Wise usage in hospitals and clinical laboratories to support market growth
    6.3 INSTRUMENTS 
           6.3.1 AUTOMATED URINE ANALYZERS
                    6.3.1.1 Integrated urine analyzers
                               6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers
                    6.3.1.2 Sediment urine analyzers
                               6.3.1.2.1 Flow cytometry analyzers
                                             6.3.1.2.1.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption
                               6.3.1.2.2 Microscopy analyzers
                                             6.3.1.2.2.1 Increased speed and accuracy of analysis to drive adoption
                    6.3.1.3 Biochemical urine analyzers
                               6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market
           6.3.2 SEMI-AUTOMATED URINE ANALYZERS
                    6.3.2.1 Extensive use in hospitals & clinics to drive segment growth
           6.3.3 POINT-OF-CARE URINE ANALYZERS
                    6.3.3.1 Need for rapid testing to drive demand for PoC urine analyzers
 
7 URINALYSIS MARKET, BY TEST TYPE (Page No. - 134)
    7.1 INTRODUCTION 
           7.1.1 PRIMARY NOTES
                    7.1.1.1 Key industry insights
    7.2 PREGNANCY & FERTILITY TESTS 
           7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE MARKET
    7.3 BIOCHEMICAL TESTS 
           7.3.1 LABORATORY TESTS
                    7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market
           7.3.2 POC TESTS
                    7.3.2.1 Convenience of PoC testing to drive segment growth
    7.4 SEDIMENT URINALYSIS 
           7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET
 
8 URINALYSIS MARKET, BY APPLICATION (Page No. - 152)
    8.1 INTRODUCTION 
           8.1.1 PRIMARY NOTES
                    8.1.1.1 Key industry insights
    8.2 DISEASE SCREENING 
           8.2.1 URINARY TRACT INFECTIONS
                    8.2.1.1 Increasing prevalence of UTIs to drive segment growth
           8.2.2 KIDNEY DISEASES
                    8.2.2.1 Rapidly growing geriatric population and increasing prevalence of kidney diseases to fuel segment growth
           8.2.3 DIABETES
                    8.2.3.1 Development of advanced analytical tools to drive market
           8.2.4 LIVER DISEASES
                    8.2.4.1 High prevalence of liver diseases to support market growth
           8.2.5 OTHER DISEASE SCREENING APPLICATIONS
    8.3 PREGNANCY & FERTILITY TESTING 
           8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
 
9 URINALYSIS MARKET, BY END USER (Page No. - 176)
    9.1 INTRODUCTION 
    9.2 DIAGNOSTIC LABORATORIES 
           9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
    9.3 HOSPITALS & CLINICS 
           9.3.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH
    9.4 HOME CARE SETTINGS 
           9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
    9.5 RESEARCH LABORATORIES & INSTITUTES 
           9.5.1 DEVELOPMENT OF INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
 
10 URINALYSIS MARKET, BY REGION (Page No. - 190)
     10.1 INTRODUCTION 
     10.2 NORTH AMERICA 
             10.2.1 NORTH AMERICA: RECESSION IMPACT
             10.2.2 US
                        10.2.2.1 Rising prevalence of chronic diseases to drive market
             10.2.3 CANADA
                        10.2.3.1 Rising burden of CKD to augment market
     10.3 EUROPE 
             10.3.1 EUROPE: RECESSION IMPACT
             10.3.2 GERMANY
                        10.3.2.1 Increasing healthcare expenditure to fuel market growth
             10.3.3 UK
                        10.3.3.1 Rising government healthcare expenditure to propel market
             10.3.4 FRANCE
                        10.3.4.1 High R&D expenditure to provide growth opportunities
             10.3.5 ITALY
                        10.3.5.1 Rising prevalence of diabetes to drive market
             10.3.6 SPAIN
                        10.3.6.1 Growing elderly population to propel market
             10.3.7 RUSSIA
                        10.3.7.1 Long-term healthcare investment initiatives by government to support market growth
             10.3.8 REST OF EUROPE
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
             10.4.2 CHINA
                        10.4.2.1 Improving healthcare infrastructure to support market growth
             10.4.3 JAPAN
                        10.4.3.1 Favorable regulatory framework to drive market growth
             10.4.4 INDIA
                        10.4.4.1 Increasing investments in healthcare system to drive market
             10.4.5 AUSTRALIA
                        10.4.5.1 Rising prevalence of chronic diseases to propel market
             10.4.6 SOUTH KOREA
                        10.4.6.1 Growing medical tourism to drive demand for urinalysis
             10.4.7 REST OF ASIA PACIFIC
     10.5 LATIN AMERICA 
             10.5.1 LATIN AMERICA: RECESSION IMPACT
             10.5.2 BRAZIL
                        10.5.2.1 Largest healthcare market in Latin America
             10.5.3 MEXICO
                        10.5.3.1 Popularity in medical tourism to drive market growth
             10.5.4 REST OF LATIN AMERICA
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 UNFAVORABLE REIMBURSEMENT POLICIES TO RESTRAIN MARKET GROWTH
             10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
     10.7 GCC COUNTRIES 
             10.7.1 RISING HEALTHCARE EXPENDITURE AND SUPPORTIVE GOVERNMENT INITIATIVES TO PROPEL MARKET
             10.7.2 GCC COUNTRIES: RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 296)
     11.1 OVERVIEW 
     11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 
             11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN URINALYSIS MARKET
     11.3 REVENUE ANALYSIS 
     11.4 MARKET SHARE ANALYSIS 
     11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
             11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        11.5.5.1 Company footprint
                        11.5.5.2 Product footprint
                        11.5.5.3 Region footprint
                        11.5.5.4 Application footprint
     11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 RESPONSIVE COMPANIES
             11.6.3 DYNAMIC COMPANIES
             11.6.4 STARTING BLOCKS
             11.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, 2023
     11.7 VALUATION AND FINANCIAL METRICS OF URINALYSIS VENDORS 
     11.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 
     11.9 COMPETITIVE SCENARIO 
             11.9.1 PRODUCT LAUNCHES
             11.9.2 DEALS
             11.9.3 EXPANSIONS
 
12 COMPANY PROFILES (Page No. - 314)
     12.1 KEY PLAYERS 
             12.1.1 SIEMENS HEALTHINEERS AG
                        12.1.1.1 Business overview
                        12.1.1.2 Products offered
                        12.1.1.3 Recent developments
                                     12.1.1.3.1 Deals
                                     12.1.1.3.2 Expansions
                        12.1.1.4 MnM view
                                     12.1.1.4.1 Key strengths
                                     12.1.1.4.2 Strategic choices
                                     12.1.1.4.3 Weaknesses & competitive threats
             12.1.2 F. HOFFMANN-LA ROCHE LTD.
                        12.1.2.1 Business overview
                        12.1.2.2 Products offered
                        12.1.2.3 MnM view
                                     12.1.2.3.1 Key strengths
                                     12.1.2.3.2 Strategic choices
                                     12.1.2.3.3 Weaknesses and competitive threats
             12.1.3 CARDINAL HEALTH
                        12.1.3.1 Business overview
                        12.1.3.2 Products offered
                        12.1.3.3 Recent developments
                                     12.1.3.3.1 Expansions
                        12.1.3.4 MnM view
                                     12.1.3.4.1 Key strengths
                                     12.1.3.4.2 Strategic choices
                                     12.1.3.4.3 Weaknesses and competitive threats
             12.1.4 DANAHER
                        12.1.4.1 Business overview
                        12.1.4.2 Products offered
                        12.1.4.3 Recent developments
                                     12.1.4.3.1 Deals
                                     12.1.4.3.2 Other developments
                        12.1.4.4 MnM view
                                     12.1.4.4.1 Key strengths
                                     12.1.4.4.2 Strategic choices
                                     12.1.4.4.3 Weaknesses and competitive threats
             12.1.5 ABBOTT
                        12.1.5.1 Business overview
                        12.1.5.2 Products offered
                        12.1.5.3 MnM view
                                     12.1.5.3.1 Key strengths
                                     12.1.5.3.2 Strategic choices
                                     12.1.5.3.3 Weaknesses and competitive threats
             12.1.6 SYSMEX CORPORATION
                        12.1.6.1 Business overview
                        12.1.6.2 Products offered
                        12.1.6.3 Recent developments
                                     12.1.6.3.1 Product launches
                                     12.1.6.3.2 Expansions
             12.1.7 THERMO FISHER SCIENTIFIC INC.
                        12.1.7.1 Business overview
                        12.1.7.2 Products offered
                        12.1.7.3 Recent developments
                                     12.1.7.3.1 Deals
             12.1.8 QUIDELORTHO CORPORATION
                        12.1.8.1 Business overview
                        12.1.8.2 Products offered
                        12.1.8.3 Recent developments
                                     12.1.8.3.1 Deals
             12.1.9 BECTON, DICKINSON AND COMPANY
                        12.1.9.1 Business overview
                        12.1.9.2 Products offered
             12.1.10 BIO-RAD LABORATORIES, INC.
                        12.1.10.1 Business overview
                        12.1.10.2 Products offered
             12.1.11 EKF DIAGNOSTICS HOLDINGS PLC
                        12.1.11.1 Business overview
                        12.1.11.2 Products offered
     12.2 OTHER PLAYERS 
             12.2.1 ARKRAY, INC.
             12.2.2 ACON LABORATORIES, INC.
             12.2.3 77 ELEKTRONIKA KFT.
             12.2.4 URIT MEDICAL ELECTRONIC CO., LTD.
             12.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
             12.2.6 DIRUI INDUSTRIAL CO., LTD.
             12.2.7 BIOBASE GROUP
             12.2.8 ERBA MANNHEIM
             12.2.9 ALPHATEC SCIENTIFIC E.I.R.L.
             12.2.10 TECO DIAGNOSTICS
             12.2.11 ANALYTICON BIOTECHNOLOGIES GMBH
             12.2.12 BIOWAY BIOLOGICAL TECHNOLOGY CO., LTD
             12.2.13 HIGH TECHNOLOGY, INC.
             12.2.14 AGAPPE DIAGNOSTICS LTD
             12.2.15 TOYOBO CO., LTD.
             12.2.16 DIALAB GMBH
             12.2.17 QUANTIMETRIX
             12.2.18 BIOCARE CORPORATION
             12.2.19 RANDOX LABORATORIES LTD.
             12.2.20 PZ CORMAY S.A.
             12.2.21 YD DIAGNOSTICS
             12.2.22 CONTEC MEDICAL SYSTEMS CO., LTD.
             12.2.23 BIOPANDA REAGENTS LTD.
 
13 APPENDIX (Page No. - 365)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 
 
 
LIST OF TABLES (483 TABLES)
 
TABLE 1 ESTIMATED NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES WORLDWIDE, BY REGION, 2021 VS. 2030 VS. 2045
TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION, 2022 VS. 2030 VS. 2050
TABLE 3 INDICATIVE PRICING FOR URINALYSIS PRODUCTS
TABLE 4 AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY REGION
TABLE 5 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 6 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 7 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 8 EUROPE: CLASSIFICATION OF DEVICES
TABLE 9 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 URINALYSIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS (%)
TABLE 17 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
TABLE 18 URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 19 KEY PRODUCTS IN URINALYSIS CONSUMABLES MARKET
TABLE 20 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 21 URINALYSIS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 22 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 23 EUROPE: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 24 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 25 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 26 KEY PRODUCTS IN PREGNANCY & FERTILITY KITS MARKET
TABLE 27 PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 NORTH AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 EUROPE: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LATIN AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 KEY PRODUCTS IN URINALYSIS DIPSTICKS/URINE TEST STRIPS MARKET
TABLE 33 DIPSTICKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 34 NORTH AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 EUROPE: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 ASIA PACIFIC: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 LATIN AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 KEY PRODUCTS IN URINALYSIS REAGENTS MARKET
TABLE 39 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 40 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 DISPOSABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 45 NORTH AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 EUROPE: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 ASIA PACIFIC: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 LATIN AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 KEY PRODUCTS IN URINALYSIS INSTRUMENTS MARKET
TABLE 50 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 51 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 52 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 KEY PRODUCTS IN AUTOMATED URINE ANALYZERS MARKET
TABLE 57 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 58 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 KEY PRODUCTS IN INTEGRATED URINE ANALYZERS MARKET
TABLE 64 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 EUROPE: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 ASIA PACIFIC: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 LATIN AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 KEY PRODUCTS IN SEDIMENT URINE ANALYZERS MARKET
TABLE 70 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 71 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 72 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 77 NORTH AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 EUROPE: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 ASIA PACIFIC: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 LATIN AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 81 MICROSCOPY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 ASIA PACIFIC: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 LATIN AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 KEY PRODUCTS IN BIOCHEMICAL URINE ANALYZERS MARKET
TABLE 87 BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 EUROPE: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 ASIA PACIFIC: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 LATIN AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 92 KEY PRODUCTS IN SEMI-AUTOMATED URINE ANALYZERS MARKET
TABLE 93 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 EUROPE: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 LATIN AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 KEY PRODUCTS IN POINT-OF-CARE URINE ANALYZERS MARKET
TABLE 99 POC URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 100 NORTH AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 EUROPE: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 ASIA PACIFIC: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 LATIN AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 105 KEY PRODUCTS IN PREGNANCY & FERTILITY TESTS MARKET
TABLE 106 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 107 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 KEY PRODUCTS IN BIOCHEMICAL TESTS MARKET
TABLE 112 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 114 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 KEY PRODUCTS IN LABORATORY TESTS MARKET
TABLE 119 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 120 NORTH AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 EUROPE: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 LATIN AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 KEY PRODUCTS IN POC TESTS MARKET
TABLE 125 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 126 NORTH AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 EUROPE: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 ASIA PACIFIC: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 LATIN AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130 KEY PRODUCTS IN SEDIMENT URINALYSIS MARKET
TABLE 131 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 132 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 137 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 139 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 144 NORTH AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 TOTAL GERIATRIC POPULATION, 2022 VS. 2030 VS. 2050 (%)
TABLE 149 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2022–2029 (USD MILLION)
TABLE 150 NORTH AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 EUROPE: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 ASIA PACIFIC: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 LATIN AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 ESTIMATED NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION)
TABLE 155 TOP TEN COUNTRIES/TERRITORIES WITH HIGHEST TOTAL HEALTH EXPENDITURE (USD) DUE TO DIABETES IN 2021, 20–79 YEARS (USD BILLION)
TABLE 156 URINALYSIS MARKET FOR DIABETES, BY REGION, 2022–2029 (USD MILLION)
TABLE 157 NORTH AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 EUROPE: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 ASIA PACIFIC: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 LATIN AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2022–2029 (USD MILLION)
TABLE 162 NORTH AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 163 EUROPE: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 164 ASIA PACIFIC: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 LATIN AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 167 NORTH AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 EUROPE: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 LATIN AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 172 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 177 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 178 NORTH AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 EUROPE: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 ASIA PACIFIC: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 LATIN AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 183 NORTH AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 EUROPE: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 ASIA PACIFIC: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186 LATIN AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION)
TABLE 188 NORTH AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 EUROPE: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 ASIA PACIFIC: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 LATIN AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 193 NORTH AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 EUROPE: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 ASIA PACIFIC: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 LATIN AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 URINALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 198 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 200 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 202 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 205 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 206 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 207 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 208 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 209 US: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 210 US: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 211 US: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 213 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 214 US: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 215 US: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 216 US: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 217 US: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 218 US: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 219 CANADA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 220 CANADA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 221 CANADA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 222 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 223 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 224 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 225 CANADA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 CANADA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 227 CANADA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 228 CANADA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 229 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 231 EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 232 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 233 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 234 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 235 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 236 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 237 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 238 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 239 EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 240 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 241 GERMANY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 242 GERMANY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 243 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 245 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 246 GERMANY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 247 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 248 GERMANY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 249 GERMANY: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 250 UK: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 251 UK: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 252 UK: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 253 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 254 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 255 UK: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 256 UK: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 257 UK: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 258 UK: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 259 UK: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 260 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 261 FRANCE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 262 FRANCE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 263 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 264 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 265 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 266 FRANCE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 267 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 268 FRANCE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 FRANCE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 270 ITALY: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 271 ITALY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 272 ITALY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 273 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 274 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 275 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 276 ITALY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 277 ITALY: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 278 ITALY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 279 ITALY: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 280 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 281 SPAIN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 282 SPAIN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 283 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 284 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 285 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 286 SPAIN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 287 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 288 SPAIN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 289 SPAIN: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 290 RUSSIA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 291 RUSSIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 292 RUSSIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 293 RUSSIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 294 RUSSIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 295 RUSSIA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 296 RUSSIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 297 RUSSIA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 298 RUSSIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 299 RUSSIA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 300 DEATHS DUE TO KIDNEY DISEASES PER 100,000 POPULATION, BY COUNTRY, 2020
TABLE 301 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 302 REST OF EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 303 REST OF EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 304 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 305 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 306 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 307 REST OF EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 308 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 309 REST OF EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 310 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 311 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 312 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 313 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 314 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 315 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 316 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 317 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 318 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 319 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 320 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 321 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 322 CHINA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 323 CHINA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 324 CHINA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 325 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 326 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 327 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 328 CHINA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 329 CHINA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 330 CHINA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 331 CHINA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 332 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 333 JAPAN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 334 JAPAN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 335 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 336 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 338 JAPAN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 339 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 340 JAPAN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 341 JAPAN: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 342 INDIA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 343 INDIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 344 INDIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 345 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 346 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 347 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 348 INDIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 349 INDIA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 350 INDIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 351 INDIA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 352 AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 353 AUSTRALIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 354 AUSTRALIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 355 AUSTRALIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 356 AUSTRALIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 357 AUSTRALIA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 358 AUSTRALIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 359 AUSTRALIA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 360 AUSTRALIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 361 AUSTRALIA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 362 SOUTH KOREA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 363 SOUTH KOREA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 364 SOUTH KOREA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 365 SOUTH KOREA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 366 SOUTH KOREA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 367 SOUTH KOREA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 368 SOUTH KOREA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 369 SOUTH KOREA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 370 SOUTH KOREA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 371 SOUTH KOREA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 372 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 373 REST OF ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 374 REST OF ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 375 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 376 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 378 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 379 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 380 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 381 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 382 LATIN AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 383 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 384 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 385 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 386 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 387 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 388 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 389 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 390 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 391 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 392 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 393 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 394 BRAZIL: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 395 BRAZIL: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 396 BRAZIL: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 397 BRAZIL: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 BRAZIL: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 399 BRAZIL: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 400 BRAZIL: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 401 BRAZIL: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 402 BRAZIL: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 403 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 404 MEXICO: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 405 MEXICO: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 406 MEXICO: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 407 MEXICO: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 408 MEXICO: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 409 MEXICO: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 410 MEXICO: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 411 MEXICO: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 412 MEXICO: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 413 REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 414 REST OF LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 415 REST OF LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 416 REST OF LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 417 REST OF LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 418 REST OF LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 419 REST OF LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 420 REST OF LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 421 REST OF LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 422 REST OF LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 423 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 424 MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 425 MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 426 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 428 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 429 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 430 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 431 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 432 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 433 GCC COUNTRIES: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 434 GCC COUNTRIES: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 435 GCC COUNTRIES: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 436 GCC COUNTRIES: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 437 GCC COUNTRIES: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 438 GCC COUNTRIES: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 439 GCC COUNTRIES: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 440 GCC COUNTRIES: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 441 GCC COUNTRIES: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 442 GCC COUNTRIES: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 443 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 444 URINALYSIS MARKET: DEGREE OF COMPETITION
TABLE 445 URINALYSIS MARKET: PRODUCT FOOTPRINT
TABLE 446 URINALYSIS MARKET: REGION FOOTPRINT
TABLE 447 URINALYSIS MARKET: APPLICATION FOOTPRINT
TABLE 448 URINALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 449 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
TABLE 450 URINALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 451 URINALYSIS MARKET: DEALS, JANUARY 2021–MAY 2024
TABLE 452 URINALYSIS MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 453 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 454 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
TABLE 455 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–MAY 2024
TABLE 456 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 457 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 458 F. HOFFMAN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 459 CARDINAL HEALTH: COMPANY OVERVIEW
TABLE 460 CARDINAL HEALTH: PRODUCTS OFFERED
TABLE 461 CARDINAL HEALTH: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 462 DANAHER: COMPANY OVERVIEW
TABLE 463 DANAHER: PRODUCTS OFFERED
TABLE 464 DANAHER: DEALS, JANUARY 2021–MAY 2024
TABLE 465 DANAHER: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2024
TABLE 466 ABBOTT: COMPANY OVERVIEW
TABLE 467 ABBOTT: PRODUCTS OFFERED
TABLE 468 SYSMEX CORPORATION: COMPANY OVERVIEW
TABLE 469 SYSMEX CORPORATION: PRODUCTS OFFERED
TABLE 470 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 471 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 472 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 473 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 474 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–MAY 2024
TABLE 475 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
TABLE 476 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
TABLE 477 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021–MAY 2024
TABLE 478 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 479 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 480 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 481 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 482 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY OVERVIEW
TABLE 483 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCTS OFFERED
 
 
LIST OF FIGURES (49 FIGURES)
 
FIGURE 1 URINALYSIS MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 5 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 6 URINALYSIS MARKET: TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 URINALYSIS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 9 URINALYSIS MARKET, BY TEST TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 10 URINALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 11 URINALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 12 URINALYSIS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
FIGURE 13 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE URINALYSIS PRODUCTS MARKET
FIGURE 15 PREGNANCY & FERTILITY TESTS SEGMENT TO DOMINATE MARKET
FIGURE 16 DISEASE SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 17 DIAGNOSTIC LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
FIGURE 18 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 19 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 20 PATENT ANALYSIS FOR FLOW CYTOMETRY (JANUARY 2014–DECEMBER 2023)
FIGURE 21 VALUE CHAIN ANALYSIS OF URINALYSIS MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
FIGURE 22 URINALYSIS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 23 URINALYSIS MARKET: ECOSYSTEM ANALYSIS
FIGURE 24 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 25 REVENUE SHIFT IN URINALYSIS MARKET
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS
FIGURE 27 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
FIGURE 28 URINALYSIS MARKET: INVESTMENT & FUNDING SCENARIO
FIGURE 29 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
FIGURE 30 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET, 2021–2023 (USD MILLION)
FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET (2023)
FIGURE 33 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 34 URINALYSIS MARKET: COMPANY FOOTPRINT
FIGURE 35 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 36 EV/EBITDA OF KEY VENDORS
FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 38 BRAND/PRODUCT COMPARISON: URINE ANALYZERS
FIGURE 39 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
FIGURE 41 CARDINAL HEALTH: COMPANY SNAPSHOT (2023)
FIGURE 42 DANAHER: COMPANY SNAPSHOT (2023)
FIGURE 43 ABBOTT: COMPANY SNAPSHOT (2023)
FIGURE 44 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 46 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
FIGURE 48 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 49 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT (2023)

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches, expansions, agreements, and partnerships of the leading players, the competitive landscape of the urinalysis market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Urinalysis  Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

F. Hoffmann-La Roche Ltd.

Sales Manager

Abbott

Sales Executive

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the urinalysis market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the urinalysis market have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Urinalysis Market Size: Bottom Up Approach

Urinalysis  Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Urinalysis Market Size: Top-Down Approach

Urinalysis  Market Size, and Share

Data Triangulation

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and manages various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical & sediment analysis. In this report, we have also discussed pregnancy & fertility tests for urine analysis.

Key Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Report Objectives

  • To define, describe, segment, and forecast the urinalysis market, by product, test type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, Latin America, and GCC countries
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as acquisitions, collaborations, partnerships, agreements, and product launches in the urinalysis market
  • To benchmark players within the urinalysis market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available Customizations

MarketsandMarkets offers the following customizations for this market report.

Country Information

  • Additional country-level analysis of the urinalysis market

Company profiles

  • Additional five company profiles of players operating in the urinalysis market.

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 3259
Published ON
Jun, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Urinalysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Want to explore hidden markets that can drive new revenue in Urinalysis Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback